SMT (Sahajanand Medical Technologies) raises INR 230 crores of Equity Capital
As part of the current transaction, a fund managed by Morgan Stanley Private Equity Asia has invested INR 160cr in primary capital into the Company for a minority stake.

As part of the current transaction, a fund managed by Morgan Stanley Private Equity Asia has invested INR 160cr in primary capital into the Company for a minority stake.
As multinational stent makers ponder their prospects in India after price controls introduced this year, their local rivals have popped up on the radar of private equity investors.
"Samara Capital is bullish on this segment and 7-8 brands which are part of the anti-infective portfolio will be acquired as part of the deal," said one of the two sources cited above.
Both the companies are also fighting another legal case over the ownership of “Guardian” brandname and royalty payments.